NovaBay Pharmaceuticals, Inc. 4
4 · NovaBay Pharmaceuticals, Inc. · Filed Jan 26, 2017
Insider Transaction Report
Form 4
SIECZKAREK MARK M
Director
Transactions
- Award
stock option (right to buy)
2017-01-25+238,609→ 936,857 totalExercise: $3.60From: 2017-01-31Exp: 2027-01-25→ Common Stock (238,609 underlying)
Footnotes (2)
- [F1]Granted pursuant to the 2007 Omnibus Incentive Plan
- [F2]Granted pursuant to the employment agreement signed between Company and Executive on May 26, 2016: Executive shall be entitled to a stock option grant equal to six percent (6%) of the aggregate number of shares issued pursuant to the Company's warrant exercises in the 2016 calendar year. Such grant shall be approved and granted by the Board at the first Board meeting in January 2017. The grant shall completely vest on January 31, 2017 in direct proportion to the percentage achievement of the stated 2016 corporate goals, as approved and determined by the Board of Directors.